Literature DB >> 9777483

Validation of a new scoring system for the Weigl Color Form Sorting Test in a memory disorders clinic sample.

L M Byrne1, R S Bucks, J M Cuerden.   

Abstract

The Bristol Memory Disorders Clinic uses the Weigl Color Form Sorting Test (CFST) to appraise abstraction and the ability to shift set. The original scoring system for the CFST (Grewal & Haward, 1984), developed on the premise that sorting to form is more difficult than sorting to color, had no score for an individual able to sort to form and subsequently unable to shift to color with a cue. Clinical experience suggested that the performance of some individuals required such a score. A new scoring system was developed and validated in a memory-disorders-clinic sample. The validation showed the new score to be necessary and gave support to the original premise that people with organic brain damage show a preference for sorting to color.

Entities:  

Mesh:

Year:  1998        PMID: 9777483     DOI: 10.1076/jcen.20.2.286.1176

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  3 in total

1.  Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.

Authors:  J Tian; R S Bucks; J Haworth; G Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

2.  An updated version of the Weigl discriminates adults with dementia from those with mild impairment and healthy controls.

Authors:  Leigh J Beglinger; Frederick W Unverzagt; Xabier Beristain; David Kareken
Journal:  Arch Clin Neuropsychol       Date:  2008-02-21       Impact factor: 2.813

3.  Mild cognitive impairment predicts institutionalization among older men: a population-based cohort study.

Authors:  Danijela Gnjidic; Fiona F Stanaway; Robert Cumming; Louise Waite; Fiona Blyth; Vasi Naganathan; David J Handelsman; David G Le Couteur
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.